Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 325

1.
2.

Rapid and efficient inactivation of IL-6 gingipains, lysine- and arginine-specific proteinases from Porphyromonas gingivalis.

Banbula A, Bugno M, Kuster A, Heinrich PC, Travis J, Potempa J.

Biochem Biophys Res Commun. 1999 Aug 11;261(3):598-602.

PMID:
10441472
3.
4.

Role of gingipains R in the pathogenesis of Porphyromonas gingivalis-mediated periodontal disease.

Genco CA, Potempa J, Mikolajczyk-Pawlinska J, Travis J.

Clin Infect Dis. 1999 Mar;28(3):456-65. Review.

PMID:
10194062
5.

Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity.

Lourbakos A, Yuan YP, Jenkins AL, Travis J, Andrade-Gordon P, Santulli R, Potempa J, Pike RN.

Blood. 2001 Jun 15;97(12):3790-7.

6.

Activation of human prothrombin by arginine-specific cysteine proteinases (Gingipains R) from porphyromonas gingivalis.

Imamura T, Banbula A, Pereira PJ, Travis J, Potempa J.

J Biol Chem. 2001 Jun 1;276(22):18984-91. Epub 2001 Mar 16.

7.

Gingipains from Porphyromonas gingivalis synergistically induce the production of proinflammatory cytokines through protease-activated receptors with Toll-like receptor and NOD1/2 ligands in human monocytic cells.

Uehara A, Imamura T, Potempa J, Travis J, Takada H.

Cell Microbiol. 2008 May;10(5):1181-9. doi: 10.1111/j.1462-5822.2008.01119.x. Epub 2008 Jan 7.

PMID:
18182086
8.

Antibodies to rat soluble IL-6 receptor stimulate B9 hybridoma cell proliferation.

Thibault V, Richards CD, Botelho F, Gauldie J.

FEBS Lett. 1997 May 19;408(2):182-6.

9.

Comparative properties of two cysteine proteinases (gingipains R), the products of two related but individual genes of Porphyromonas gingivalis.

Potempa J, Mikolajczyk-Pawlinska J, Brassell D, Nelson D, Th√łgersen IB, Enghild JJ, Travis J.

J Biol Chem. 1998 Aug 21;273(34):21648-57.

10.

Role of soluble interleukin-6 receptor in inflamed gingiva for binding of interleukin-6 to gingival fibroblasts.

Naruishi K, Takashiba S, Chou HH, Arai H, Nishimura F, Murayama Y.

J Periodontal Res. 1999 Aug;34(6):296-300.

PMID:
10633884
12.

Expression of Arg-Gingipain RgpB is required for correct glycosylation and stability of monomeric Arg-gingipain RgpA from Porphyromonas gingivalis W50.

Rangarajan M, Hashim A, Aduse-Opoku J, Paramonov N, Hounsell EF, Curtis MA.

Infect Immun. 2005 Aug;73(8):4864-78.

13.

Cytokines oncostatin M and interleukin 1 regulate the expression of the IL-6 receptor (gp80, gp130).

Geisterfer M, Richards CD, Gauldie J.

Cytokine. 1995 Aug;7(6):503-9.

PMID:
8580365
14.

Porphyromonas gingivalis gingipains: the molecular teeth of a microbial vampire.

O-Brien-Simpson NM, Veith PD, Dashper SG, Reynolds EC.

Curr Protein Pept Sci. 2003 Dec;4(6):409-26. Review.

PMID:
14683427
15.
16.

The role of gingipains in the pathogenesis of periodontal disease.

Imamura T.

J Periodontol. 2003 Jan;74(1):111-8. Review.

PMID:
12593605
17.

Activation of protein C by arginine-specific cysteine proteinases (gingipains-R) from Porphyromonas gingivalis.

Hosotaki K, Imamura T, Potempa J, Kitamura N, Travis J.

Biol Chem. 1999 Jan;380(1):75-80.

PMID:
10064139
18.
19.
20.

Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts.

Vermes C, Jacobs JJ, Zhang J, Firneisz G, Roebuck KA, Glant TT.

J Biol Chem. 2002 May 10;277(19):16879-87. Epub 2002 Mar 7.

Supplemental Content

Support Center